OXAPEX

Welcome to the Brand page for “OXAPEX”, which is offered here for Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposes, sterile solutions for use in oxygen therapeutics for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, gastrointestinal and hepatobiliary system disease, cardiovascular and hematopoietic system diseases, respiratory system diseases, central nervous system diseases, musculo-skeletal system diseases, hormones related diseases, oncology diseases, genito-urinary system diseases, endocrine and metabolic system diseases, eye diseases, ear and mouth or throat diseases, skin diseases, allergy and immune system diseases; biological preparations for medical and veterinary purposes, hemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, gastrointestinal and hepatobiliary system disease, cardiovascular and hematopoietic system diseases, respiratory system diseases, central nervous system diseases, musculo-skeletal system diseases, hormones related diseases, oncology diseases, genito-urinary system diseases, endocrine and metabolic system diseases, eye diseases, ear and mouth or throat diseases, skin diseases, allergy and immune system diseases; biological preparations for medical and veterinary purposes, protein arrays, biological tissue cultures, blood, blood plasma, and blood serums for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, gastrointestinal and hepatobiliary system disease, cardiovascular and hematopoietic system diseases, respiratory system diseases, central nervous system diseases, musculo-skeletal system diseases, hormones related diseases, oncology diseases, genito-urinary system diseases, endocrine and metabolic system diseases, eye diseases, ear and mouth or throat diseases, skin diseases, allergy and immune system diseases;.

Its status is currently believed to be active. Its class is unavailable. “OXAPEX” is believed to be currently owned by “First Gain International Limited”.